$1.51
-0.07-4.43%
At close: -
$1.63
0.127.95%
After Hours: 8:57 AM EDT
Marker Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Marker Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.26 | $-0.39 | 33.3 % |
Q2 | 2024-08-14 | $-0.25 | $-0.43 | 41.9 % |
Q1 | 2023-05-15 | $-0.57 | $-0.80 | 28.7 % |
Q4 | 2023-03-22 | $-0.45 | $-1.60 | 71.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $1.93M | $1.00M | 92.6 % |
Q3 | 2022-11-10 | $3.95M | $270.00K | 1363.0 % |
Q2 | 2022-08-11 | $790.51K | $670.00K | 18.0 % |
Marker Therapeutics (MRKR) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.26, which beat the estimate of $-0.39.
The Actual Revenue was $1.9M, which beat the estimate of $1M.
Browse earnings estimates, EPS, and revenue on all stocks.